HanAll Biopharma Appoints Christopher W Slavinsky as Chief Business Development and Legal Officer
- Written by PR Newswire
![]() |
ROCKVILLE, Md. and SEOUL, South Korea, July 15, 2024 /PRNewswire/ -- HanAll Biopharma (KRX: 009420.KS) announced today the appointment of Christopher W. Slavinsky as Chief Business Development and Legal Officer.
"Chris brings a wealth of expertise...















